The investments come amid an ongoing investment fraud probe into AstraZeneca’s former China head Leon Wang—and despite ...

British-Swedish drug maker has gone from Beijing’s scrutiny to its praise, hailed as a sign of doing business in China.

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre ...

Johnson & Johnson will invest $55 billion in the U.S. over the next four years. The announcement comes a month after Eli ...

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...

The new centre will focus on early-stage research and clinical development, supported by data science and AI labs.

AstraZeneca makes a deal to buy another biotech company, this one with a price tag that could reach $1 billion.

HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...

AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...

Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.

Tallying up a wide range of investments, AstraZeneca said it is pumping $2.5 billion into Beijing. The figure includes ...